Savara Inc (SVRA) Stock Price & Analysis
Savara Inc (SVRA) rose 0.00% to USD 5.37 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
SVRA last closed at USD 5.37; the session ranged USD 5.31–5.39 on volume of 625,457 shares. Market capitalization is —, with a 52-week range of USD 3.34–7.01 (NMS). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 5.37 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 5.37 |
| Open | USD 5.37 |
| Day Range | USD 5.31 – 5.39 |
| 52-Week Range | USD 3.34 – 7.01 |
| Volume | 625,457 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SVRA)
Nexqual's technical model rates SVRA "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.69 (neutral) |
| vs SMA50 | Below (USD 5.65) |
| MACD | -0.05 (negative) |
From Savara Inc's Latest SEC 10-K Filing (filed 2026-03-13)
Partnerships
- Below is a summary of some of the material risks associated with our business and investment in our securities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | USD 5.34 | ▼ 0.74% |
| SLDB | Solid Biosciences Inc. | USD 10.25 | ▼ 0.34% |
| SYBX | Synlogic, Inc. | USD 1.17 | ▼ 4.1% |
| XERS | Xeris Biopharma Holdings, Inc. | USD 8.53 | ▼ 0.58% |
| MRKR | Marker Therapeutics, Inc. | USD 1.18 | ▼ 5.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.